Suppr超能文献

人卵巢组织体外培养:原始卵泡激活作为女性生育力保存的新策略。

Human ovarian tissue in-vitro culture: primordial follicle activation as a new strategy for female fertility preservation.

作者信息

Ghezelayagh Zeinab, Khoshdel-Rad Niloofar, Ebrahimi Bita

机构信息

Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

Department of Developmental Biology, Faculty of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, ACECR, Tehran, Iran.

出版信息

Cytotechnology. 2022 Feb;74(1):1-15. doi: 10.1007/s10616-021-00510-2. Epub 2022 Jan 4.

Abstract

Cryopreservation and transplantation of ovarian tissue is the only fertility preservation option used for prepubertal girls and women who don't have a chance for embryo or oocyte vitrification. For women with aggressive cancer, hormone-responsive malignancies, autoimmune diseases, etc. ovary transplantation cannot be performed so an alternative technology called in-vitro follicle activation is thinkable. In this method, dormant primordial follicles are activated from the resting primordial pool by in-vitro culture and enter their growth phase. Different in-vitro culture media and supplements in addition to various culturing methods have been conducted for activating these dormant follicles. Furthermore, several signaling pathways such as Hippo, phosphatidylinositol-3-kinase, and mTOR influence follicle activation. Therefore, the addition of different activators of these signaling pathways can beneficially regulate this culture system. This review summarizes the findings on different aspects of human ovarian tissue culture strategies for in-vitro follicular activation, their medium, and different factors involved in this activation. Afterward, signaling pathways important for follicle activation and their clinical applications towards improving activation in culture are also reviewed.

摘要

卵巢组织的冷冻保存和移植是用于青春期前女孩和没有机会进行胚胎或卵母细胞玻璃化冷冻的女性的唯一生育力保存选择。对于患有侵袭性癌症、激素反应性恶性肿瘤、自身免疫性疾病等的女性,无法进行卵巢移植,因此一种名为体外卵泡激活的替代技术是可行的。在这种方法中,休眠的原始卵泡通过体外培养从静止的原始卵泡池中被激活并进入生长阶段。除了各种培养方法外,还使用了不同的体外培养基和添加剂来激活这些休眠卵泡。此外,几种信号通路,如Hippo、磷脂酰肌醇-3-激酶和mTOR,会影响卵泡激活。因此,添加这些信号通路的不同激活剂可以有益地调节这个培养系统。本综述总结了关于人类卵巢组织培养策略在体外卵泡激活的不同方面、其培养基以及参与这种激活的不同因素的研究结果。随后,还综述了对卵泡激活重要的信号通路及其在改善培养中激活方面的临床应用。

相似文献

本文引用的文献

8
Activation Prior to Transplantation of Human Ovarian Tissue: Is It Truly Effective?人卵巢组织移植前的激活:它真的有效吗?
Front Endocrinol (Lausanne). 2019 Aug 2;10:520. doi: 10.3389/fendo.2019.00520. eCollection 2019.
10
Future developments: In vitro growth (IVG) of human ovarian follicles.未来的发展:人类卵巢滤泡的体外生长(IVG)。
Acta Obstet Gynecol Scand. 2019 May;98(5):653-658. doi: 10.1111/aogs.13592. Epub 2019 Apr 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验